Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2011-10-06Clinical Trial Update: The Occurrence of the ApoE4 Allele in Agitated In-Patients With Late-Onset Alzheimer's Disease
A completed clinical trial update analyzing the occurrence of the ApoE4 allele in agitated in-patients with late-onset Alzheimer's disease.
-
CLINICAL_TRIALS research · 2011-09-29Clinical Trial Update: Functional Magnetic Resonance Imaging (fMRI) of Anosognosia in Amnestic Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD)
Notes that the study NCT00908999, an fMRI investigation of anosognosia in amnestic mild cognitive impairment and Alzheimer's disease, has co…
-
CLINICAL_TRIALS research · 2011-07-27Clinical Trial Update: Innovative Biomarkers in Alzheimer's Disease and Frontotemporal Dementia (FTD): Preventative and Personalized
This clinical trial update discusses innovative biomarkers for Alzheimer's disease and frontotemporal dementia to support preventative and p…
-
CLINICAL_TRIALS research · 2011-06-22Clinical Trial Update: Study of the Role of G72 in Amyotrophic Lateral Sclerosis: Biomarker Discovery and Mechanism Investigation
A clinical trial investigating the role of the G72 gene in amyotrophic lateral sclerosis, focusing on biomarker discovery and mechanism inve…
-
CLINICAL_TRIALS research · 2011-04-29Clinical Trial Update: Use of Autobiographical and Interest Assessment for a Better Stimulation of Patients in Nursing Home [NA]
This entry reports on a clinical trial exploring a non-pharmacologic approach using autobiographical and interest assessments to better stim…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2011-04-06Clinical Trial Update: Effect of Cognitive Intervention in Alzheimer's Disease (AD) on Functional Cortical Networks in fMRI [Phase 4]
A Phase 4 clinical trial update evaluating a cognitive intervention for Alzheimer's disease and its effects on functional brain networks as …
-
CLINICAL_TRIALS research · 2011-04-06Clinical Trial Update: Computerized Personal Interventions for Alzheimer's Patients [NA]
Clinical trial update on computerized personal interventions for patients with Alzheimer's disease; the current status of the trial is unkno…
-
CLINICAL_TRIALS research · 2011-03-24Clinical Trial Update: A Study of Alzheimer's Disease Using Magnetoencephalography (MEG) and the Synchronous Neural Interaction™ Test
This is a clinical trial update describing a study of Alzheimer's disease using magnetoencephalography (MEG) and the Synchronous Neural Inte…
-
CLINICAL_TRIALS research · 2011-03-15Clinical Trial Update: Alzheimer's Disease and Related Disorders
Clinical trial update related to Alzheimer's disease and related disorders. The sponsor is University Hospital, Angers, with conditions list…
-
CLINICAL_TRIALS research · 2011-03-14Clinical Trial Update: Study of Adherence and Effects of Balance Exercices (SIEL BLEU Associatio)
Ongoing clinical trial update from University Hospital Angers assessing adherence to and effects of balance exercises in individuals with Al…
-
CLINICAL_TRIALS research · 2011-02-17Clinical Trial Update: AIDMA: A Psycho-educational Program Designed to Support and Train Carers of Alzheimer's Disease (AD) Patients [NA]
This clinical trial update notes the completion of a study evaluating AIDMA, a psycho-educational program designed to support and train care…
-
CLINICAL_TRIALS research · 2011-02-07Clinical Trial Update: Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of BMS-708163 [Phase 1]
This document summarizes a Phase 1 study evaluating the pharmacokinetics, safety, and tolerability of BMS-708163 in Alzheimer's disease. The…
-
CLINICAL_TRIALS research · 2011-01-28Clinical Trial Update: Trial of Novel Oral Zinc Cysteine Preparation in Alzheimer's Disease [Phase 1, Phase 2]
A clinical trial update describes a Phase 1/Phase 2 study of a novel oral zinc cysteine preparation for Alzheimer's disease and mild cogniti…
-
CLINICAL_TRIALS research · 2011-01-25Clinical Trial Update: Study of Huperzine A Sustained-Release Tablets in Patients With Alzheimer's Disease [Phase 2, Phase 3]
A clinical trial is investigating Huperzine A sustained-release tablets for Alzheimer's disease in Phase 2 and Phase 3. The current status o…
-
CLINICAL_TRIALS research · 2010-12-07Clinical Trial Update: A Phase I, Single Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease [Phase 1]
Pfizer conducted a Phase I single-dose study of PF-04360365 in Japanese patients with mild to moderate Alzheimer's disease; the trial status…
-
CLINICAL_TRIALS research · 2010-11-18Clinical Trial Update: Study of Uptake, Break Down and Elimination of an Investigational Drug in Healthy Volunteers [Phase 1]
AstraZeneca conducted a Phase 1 study to characterize the uptake, breakdown, and elimination of an unnamed investigational drug in healthy v…
-
CLINICAL_TRIALS research · 2010-11-09Clinical Trial Update: Continuous Arterial Spin Labeling (CASL) MRI for Monitoring and Prediction of Drug Therapy in Alzheimers Disease (AD) [NA]
This clinical trial update discusses the use of Continuous Arterial Spin Labeling MRI to monitor and predict responses to drug therapy in Al…
-
CLINICAL_TRIALS research · 2010-07-26Clinical Trial Update: Evolution of Memory Related Activity
Clinical trial update on memory-related activity involving Alzheimer's disease and mild cognitive impairment; current status is unknown.
-
CLINICAL_TRIALS research · 2010-07-16Clinical Trial Update: Encapsulated Cell Biodelivery of Nerve Growth Factor to Alzheimer´s Disease Patients [Phase 1]
Phase 1 clinical trial evaluating encapsulated cell biodelivery of nerve growth factor for Alzheimer's disease patients.
-
CLINICAL_TRIALS research · 2010-01-25Clinical Trial Update: Disease-modifying Properties of Lithium in the Neurobiology of Alzheimer's Disease [Phase 2]
A Phase 2 clinical trial is investigating whether lithium has disease-modifying effects in Alzheimer's disease.
-
CLINICAL_TRIALS research · 2009-12-30Clinical Trial Update: A Phase 1, Non-Randomized, Open-Label, Single-Dose Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF 01913539] In Subjects With Severely-Impaired And Normal Renal Function [Phase 1]
A Phase 1, non-randomized, open-label pharmacokinetics and safety study of Dimebon (latrepirdine) in subjects with severely impaired and nor…
-
CLINICAL_TRIALS research · 2009-12-29Clinical Trial Update: Amyloid Plaque and Tangle Imaging in Alzheimer's Disease and Down Syndrome
The National Institute on Aging reports an imaging-focused clinical trial studying amyloid plaques and tau tangles in Alzheimer's disease an…
-
CLINICAL_TRIALS research · 2009-12-29Clinical Trial Update: Glucose Metabolic, Amyloid, and Tau Brain Imaging in Down Syndrome and Dementia
This entry notes an ongoing clinical trial from the National Institute on Aging evaluating glucose metabolism, amyloid, and tau brain imagin…
-
CLINICAL_TRIALS research · 2009-12-29Clinical Trial Update: Implications of Amyloid Pathology
Clinical trial update from the National Institute on Aging discusses the implications of amyloid pathology for Alzheimer's disease.
-
CLINICAL_TRIALS research · 2009-12-14Clinical Trial Update: Predictors of Cognitive Decline in Normal Aging
A National Institute on Aging–sponsored clinical trial investigates predictors of cognitive decline in normal aging. The study references co…